Michel Drancourt
2
Documents
Identifiants chercheurs
michel-drancourt- IdRef : 060258411
-
0000-0003-0768-1139
- VIAF : 172769318
Présentation
Publications
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisTravel Medicine and Infectious Disease, 2020, 36, pp.101791. ⟨10.1016/j.tmaid.2020.101791⟩
Article dans une revue
hal-03138793v1
|
|
|
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational studyTravel Medicine and Infectious Disease, 2020, pp.101663. ⟨10.1016/j.tmaid.2020.101663⟩
Article dans une revue
hal-02547911v1
|